Clinical Trial 41938


Chicago, IL 60617

Study Summary:

This study is a Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of Olorinab in Subjects with Irritable Bowel Syndrome Experiencing Abdominal Pain

Qualified Participants Must:

• Be male or female
• 18 to 70 years old
• Clinical diagnosis of Irritable Bowel Syndrome

Qualified Participants May Receive:

  • Compensation for participation and travel
  • Free consultation at our Hyde Park office
  • Travel provided from our Hyde Park office to our Stony Island office

Study is Available At:

Claude Mandel Medical Center
8507 S. Stony Island Ave
Chicago, IL 60617
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.